2-fluoro-N-{[4-(6-methylpyridin-2-yl)-5-{[1,2,4]triazolo[1,5-a]pyridin-6-yl}-1H-imidazol-2-yl]methyl}aniline, 98%, 250mg

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity), 97%, 50mg

3,5-Diaminobenzoic acid, 95.0%, 100g

2-Methyl-6-nitrobenzoic acid, 98.0%, 500g

Syringe filters ROTILABO® Polyvinylidene fluoride (PVDF), 0,2 µm, 25 mm, Sterile, 100 Piece(s)

2-[2-(1-methyl-1H-imidazol-2-yl)ethyl]piperidine dihydrochloride, 95.0%, 1g

N-(4-methoxy-1,3-benzothiazol-2-yl)-N-methylglycine, 95.0%, 500mg

(R)-1-(3-Chloro-5-fluorophenyl)ethanamine hydrochloride, 95.0%, 100mg

2-(3-Phenoxyphenyl)propanoic acid, 95.0%, 1g

Ethyl 2-(o-tolyl)acetate, 95.0%, 5g

2-chloro-N-[4-(4-chlorophenoxy)phenyl]acetamide, 1g

6-Methyl-7-oxo-6,7-dihydro-1h-pyrrolo[2,3-c]pyridine-4-carboxylic acid, 95%, 1g

GONDOIC ACID, 95%, 100mg